IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes-Reference-Cited by-同舟云学术

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

Published:2011-12-16 Issue:2 Volume:55 Page:384-394
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Bochud Pierre-Yves,Bibert Stéphanie,Kutalik Zoltán,Patin Etienne,Guergnon Julien,Nalpas Bertrand,Goossens Nicolas,Kuske Lorenz,Müllhaupt Beat,Gerlach Tillman,Heim Markus H.,Moradpour Darius,Cerny Andreas,Malinverni Raffaele,Regenass Stephan,Dollenmaier Guenter,Hirsch Hans,Martinetti Gladys,Gorgiewski Meri,Bourlière Marc,Poynard Thierry,Theodorou Ioannis,Abel Laurent,Pol Stanislas,Dufour Jean-François,Negro Francesco,

Publisher

Wiley

Subject

Hepatology

Reference50 articles.

1. Natural history of chronic hepatitis C;Seeff;HEPATOLOGY,2002

2. EASL Clinical Practice Guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

3. What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?;Alberti;Liver Int,2009

4. Pegylated-interferon plus ribavirin therapy in the treatment of CHC: individualization of treatment duration according to on-treatment virologic response;Zeuzem;Curr Med Res Opin,2010

5. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus;Thomas;Nature,2009

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A literature review of genetics and epigenetics of HCV-related hepatocellular carcinoma: translational impact;Hepatobiliary Surgery and Nutrition;2024-08

2. HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma;Heliyon;2023-11

3. Epigenetic memory of environmental exposures as a mediator of liver disease;Hepatology;2023-04-21

4. Hepatitis C virus‐specific immune responses following direct‐acting antivirals administered during recent hepatitis C virus infection;Journal of Viral Hepatitis;2022-11-13

5. The presence of interferon affects the progression of non-alcoholic fatty liver disease;Genes & Immunity;2022-06-20